Experimental combination and single-agent chemotherapy in human lung-tumour xenografts.

[1]  F. Greco,et al.  Small-cell lung cancer , 1979, Cancer Chemotherapy and Pharmacology.

[2]  V. Devita,et al.  Current results of the screening program at the Division of Cancer Treatment, National Cancer Institute. , 1981, European journal of cancer.

[3]  P. Bunn,et al.  Small Cell Bronchogenic Carcinoma: A Review of Therapeutic Results , 1981 .

[4]  A. Shorthouse,et al.  The human tumour xenograft—a valid model in experimental chemotherapy? , 1980, The British journal of surgery.

[5]  V. Courtenay,et al.  The Ara-C pretreated mouse as a host for human tumour xenografts. , 1980, The British journal of cancer. Supplement.

[6]  A. Shorthouse,et al.  The therapeutic response of bronchial carcinoma xenografts: a direct patient-xenograft comparison. , 1980, The British journal of cancer. Supplement.

[7]  V. Courtenay,et al.  The therapeutic response of human tumour xenografts , 1980 .

[8]  D. Porteous,et al.  Tumour-cell killing by X-rays and immunity quantitated in a mouse model system. , 1979, British Journal of Cancer.

[9]  A. Ribas,et al.  Results of two sequential chemotherapy studies in WHO Types I, III and IV lung cancer: cyclophosphamide-5-fluorouracil (CF) and cyclophosphamide-5-fluorouracil-adriamycin (CAF). , 1979, European journal of cancer.

[10]  R. Livingston.  Treatment of small cell carcinoma: evolution and future directions. , 1978, Seminars in oncology.

[11]  V. Courtenay,et al.  Improved immune-suppression techniques for the exongrafting of human tumours. , 1978, British Journal of Cancer.

[12]  D. Taylor,et al.  Maintenance of biological and biochemical characteristics of human colorectal tumours during serial passage in immune-deprived mice. , 1978, British Journal of Cancer.

[13]  G. Steel.  The growth and therapeutic response of human tumours in immune deficient mice. , 1978, Bulletin du cancer.

[14]  J. Peacock,et al.  Tumour volume response, initial cell kill and cellular repopulation in B16 melanoma treated with cyclophosphamide and 1-(2-chloroethyl)-3-cyclohexyl-1-nitrosourea. , 1977, British Journal of Cancer.

[15]  J. Minna,et al.  Advances in small cell bronchogenic carcinoma. , 1977, Cancer treatment reports.

[16]  G. Steel,et al.  The therapeutic response of three human tumor lines maintained in immune-suppressed mice. , 1975, Cancer research.

[17]  S. Spivack.  Drugs 5 years later: procarbazine. , 1974, Annals of internal medicine.

[18]  Giovanella Bc,et al.  Heterotransplantation of human malignant tumors in "nude" thymusless mice. I. Breeding and maintenance of "nude" mice. , 1973 .

[19]  M. Bychkov,et al.  [Chemotherapy of lung cancer]. , 1972, Voprosy onkologii.

[20]  W. R. Bruce,et al.  Comparison of the dose- and timesurvival curves for normal hematopoietic and lymphoma colony-forming cells exposed to vinblastine, vincristine, arabinosylcytosine, and amethopterin. , 1969, Journal of the National Cancer Institute.

[21]  E J Freireich,et al.  Quantitative comparison of toxicity of anticancer agents in mouse, rat, hamster, dog, monkey, and man. , 1966, Cancer chemotherapy reports.